Mirabegron


( Last Updated : March 8, 2013)
Generic Name:
Mirabegron
Project Status:
Withdrawn
Therapeutic Area:
Overactive bladder
Manufacturer:
Astellas Pharma Canada, Inc.
Call for patient/clinician input open:
Brand Name:
Myrbetriq
Project Line:
Reimbursement Review
Project Number:
SR0319-000
Call for patient/clinician input closed:

Details


Submission Type:
Initial
Indications:
Bladder, Overactive